Key result
1-methylnicotinamide (1-MNA) ameliorated high-fat diet-induced cardiac hypertrophy, apoptosis, and myocardial fibrosis in mice by upregulating Nrf2 expression and inhibiting the NF-κB pathway.
Why the study?
High free fatty acid levels are associated with cardiovascular disease, and researchers sought to explore the underlying mechanisms of NAD metabolism linked to cardiovascular disease risk.
1-MNA demonstrates protective effects against high fat diet and palmitic acid-induced heart injury in preclinical models by regulating Nrf2 and NF-κB pathways.
High levels of free fatty acids (FFA) are closely associated with obesity and the development of cardiovascular diseases. Recently, nicotinamide adenine dinucleotide (NAD) metabolism has emerged as a potential target for several modern diseases including diabetes. Herein, we explored the underlying mechanisms of NAD metabolism associated with the risk of cardiovascular disease. Our study found that nicotinamide N-methyltransferase (NNMT) mRNA levels were significantly increased in the hearts of FFA-bound-albumin-overloaded mice and in H9C2 cells treated with palmitic acid (PA). We studied the mechanisms underlining the anti-inflammatory and anti-oxidant activities of 1-methylnicotinamide (1-MNA), a metabolite of NNMT. We found a significantly higher level of reactive oxygen species, inflammation, apoptosis, and cell hypertrophy in PA-treated H9C2 cells and this effect was inhibited by 1-MNA treatment. in vivo , 1-MNA improved inflammation, apoptosis, and fibrosis damage in mice and this inhibition was associated with inhibited NF-κB activity. In conclusion, our study revealed that 1-MNA may prevent high fatty diet and PA-induced heart injury by regulating Nrf2 and NF-κB pathways.
No takes yet. Share an insight, caveat, or question.
Song et al. (2021) studied High Fat Diet-Induced Heart Injury (n=30). 1-methylnicotinamide (1-MNA) vs. High-fat diet (HFD) was evaluated on Heart weight/tibia length (HW/TL) ratio (p=<0.001). 1-methylnicotinamide (1-MNA) ameliorated high-fat diet-induced cardiac hypertrophy, apoptosis, and myocardial fibrosis in mice by upregulating Nrf2 expression and inhibiting the NF-κB pathway.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: